Hutchison China MediTech Limited (LON:HCM) insider Michael Howell sold 15,000 shares of the firm’s stock in a transaction dated Friday, October 7th. The stock was sold at an average price of GBX 1,790 ($22.15), for a total transaction of £268,500 ($332,301.98).

Hutchison China MediTech Limited (LON:HCM) opened at 1830.00 on Wednesday. The company’s market capitalization is GBX 1.11 billion. The company’s 50-day moving average is GBX 1,820.62 and its 200 day moving average is GBX 1,846.45. Hutchison China MediTech Limited has a one year low of GBX 1,612.50 and a one year high of GBX 2,896.60.

A number of research firms have recently commented on HCM. Panmure Gordon reaffirmed an “under review” rating on shares of Hutchison China MediTech Limited in a report on Monday, August 1st. Beaufort Securities reissued a “buy” rating on shares of Hutchison China MediTech Limited in a report on Tuesday, June 21st.

Hutchison China MediTech Limited Company Profile

Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market.

Receive News & Stock Ratings for Hutchison China MediTech Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hutchison China MediTech Limited and related stocks with our FREE daily email newsletter.